Join the Squamous Cell Carcinoma group to help and get support from people like you.
Squamous Cell Carcinoma News
Related terms: Cancer, Squamous Cell Carcinoma, Skin Cancer, Squamous Cell, SCC
Prevalence of Skin Cancer Varies for Sexual Minority, Heterosexual Adults
FRIDAY, July 19, 2024 – With respect to their lifetime prevalence of skin cancer, sexual minority (SM) adults differ across racial and ethnic groups and among males and females, according to a study...
Respect Summer's Scorching Heat, Experts Warn
SATURDAY, July 13, 2024 – The human body is no match for extreme heat, and scorching temperatures seem to be the rule rather than the exception these days. "It's hard to think of an organ that is...
Have Fun in the Sun, But Protect Your Skin, Expert Says
SUNDAY, July 14, 2024 — Roughly 20% of Americans are diagnosed with skin cancer at some point in their lives, but it's not inevitable. Skin cancer is not only the most common cancer, it's also the m...
Rural Residents Continue to Have Higher Odds of Skin Cancer
TUESDAY, July 9, 2024 – Urban-rural disparities in skin cancer prevalence continue to persist, according to a study published in the June issue of the Journal of Drugs in Dermatology. Rachel R. Lin, ...
Outdoor Workers Face Skin Cancer Danger
FRIDAY, May 10, 2024 – Steve Murray, 68, has spent a lot of time out in the sun, at work and at play. Murray worked construction for several decades, and as a child spent summers on the beach in...
'Virtual Biopsy' Tests Skin Lesions Without a Scalpel
FRIDAY, April 12, 2024 – Folks with a suspicious-looking mole or questionable skin lesion often have to endure a scalpel or shaver so their doctor can cut off a sample to send in for biopsy. But a...
Military Service Can Bring Melanoma Danger
TUESDAY, March 12, 2024 — U.S. military veterans, especially those who served in the Air Force, are at high risk for one of the deadliest skin cancers, melanoma. The risk owes to work hazards a...
FDA Approves AI Device That Helps Spot Skin Cancer
THURSDAY, Jan. 18, 2024 (HealthDay news) – The first medical device powered by artificial intelligence and designed to help doctors catch skin cancer has been approved by the U.S. Food and Drug...
Occupational Exposure to Solar UVR Linked to Nonmelanoma Skin Cancer
MONDAY, Nov. 20, 2023 – Occupational exposure to solar ultraviolet radiation (UVR) is associated with a substantial burden of nonmelanoma skin cancer (NMSC), according to a study published in the...
AI Getting Better at Detecting Skin Cancer
FRIDAY, Nov. 3, 2023 – Artificial intelligence (AI) is increasingly accurate in detecting skin cancer, according to a study presented at the annual meeting of the European Academy of Dermatology and...
Cervical Cancer: What It Is, Symptoms and Treatment
Cervical cancer is a diagnosis no woman wants to receive, and navigating the disease can be challenging. A type of cancer that starts in the cells of the cervix, this cancer usually develops slowly....
AI Pipeline Can Accurately Measure Sarcopenia in Head and Neck Cancer
MONDAY, Aug. 14, 2023 – A fully automated deep learning pipeline can accurately measure sarcopenia in head and neck squamous cell carcinoma (HNSCC), which is associated with disease outcomes,...
FDA Approves Expanded Indication for Merck’s Keytruda (pembrolizumab) in Locally Advanced Cutaneous Squamous Cell Carcinoma (cSCC)
Keytruda Is Now Approved for the Treatment of Patients With Recurrent or Metastatic or Locally Advanced cSCC That Is Not Curable by Surgery or Radiation KENILWORTH, N.J.--(BUSINESS WIRE) July 6, ...
FDA Approves Merck’s Keytruda (pembrolizumab) for the Treatment of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) that is Not Curable by Surgery or Radiation
KENILWORTH, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved Keytruda,...
FDA Approves Libtayo (cemiplimab-rwlc) for Advanced Cutaneous Squamous Cell Carcinoma
September 28, 2018 – The U.S. Food and Drug Administration today approved Libtayo (cemiplimab-rwlc) injection for intravenous use for the treatment of patients with metastatic cutaneous squamous...
Ask a question
To post your own question to this support group, sign in or create an account.